FDA tells GLP-1 makers to warn of potential vision loss side effect

Feed excerpt — reported by Washington Post

The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Washington Post →

View MAP Context →